Haiti sees first African swine fever outbreak in 37 years

News
391

Translate to Spanish or other 102 languages!

A pig pokes its nose through a fence in Harrisburg, Pa., in this January 2013 file photo. (The Patriot-News/Joe Hermitt)
A pig pokes its nose through a fence in Harrisburg, Pa., in this January 2013 file photo. (The Patriot-News/Joe Hermitt)

CTV NEWS – CHICAGO – Haiti has its first outbreak of the fatal pig virus African swine fever in 37 years, the World Organization for Animal Health said, fueling concerns about the disease’s spread in the Americas.

- Advertisement -

The organization, known as the OIE, said in a report on Monday that one backyard farm in Anse-à-Pitre, near Haiti’s border with the Dominican Republic, suffered an outbreak that began on Aug. 26.

Click the link to read the entire story:  https://www.ctvnews.ca/health/haiti-sees-first-african-swine-fever-outbreak-in-37-years-1.5594671

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Weather can affect pain tolerance, reports study in PAIN®
Next article
No esperes más iVacúnate hoy!

More Articles

How Dogs Benefit Mind and Soul

"Dogs are wonderful greeters. They're waiting for you to come home, and they're always happy to see you. In turn, this increases our feel-good hormones, like dopamine and serotonin,” explained Chivonna Childs, PhD.

Data Reveals US Illicit Fentanyl Use is Double That of Clinical Care

The largest study to date that quantifies and compares medical and illegal use of fentanyl in the United States suggests that illicit use is more than twice as common as medically based use. 

7 Crucial Caregiving Truths Families Often Overlook

If you clicked to read this story, or someone sent it to you, congratulations: You’re a caregiver.

Moderna and Merck Report Positive Phase 3 Results for Personalized Cancer Therapy

Moderna and Merck have reached a major clinical milestone after their investigational individualized cancer therapy, combined with Merck’s Keytruda, produced positive results in a Phase 3 study involving patients with high-risk melanoma.
- Advertisement -